Cannabis Science Buy Hold or Sell Recommendation

CBIS -- USA Stock  

USD 0.0296  0.0004  1.33%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Cannabis Science is 'Strong Sell'. Macroaxis provides Cannabis Science buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CBIS positions. The advice algorithm takes into account all of Cannabis Science available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CBIS buy-and-hold prospective. Check also Cannabis Science Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Cannabis ScienceBuy Cannabis Science
Strong Sell

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon Cannabis Science has a mean deviation of 2.36, semi deviation of 0.0, standard deviation of 3.03, variance of 9.15, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on Cannabis Science. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Cannabis Science is not overpriced, please confirm all Cannabis Science fundamentals including its Net Income as well as the relationship between Earnings Per Share and Retained Earnings . As Cannabis Science appears to be a penny stock we also recommend to validate its Price to Earning numbers.

Cannabis Science Trading Alerts and Improvement Suggestions

Cannabis Science generates negative expected return over the last 30 days
Cannabis Science has some characteristics of a very speculative penny stock
Cannabis Science has high historical volatility and very poor performance
Cannabis Science has high likelihood to experience some financial distress in the next 2 years
The company currently holds 2.73M in liabilities. Cannabis Science has Current Ratio of 0.09 indicating that it has a negative working capital and may not be able to pay financial obligations when they are due.
The entity reported previous year revenue of 7.04K. Net Loss for the year was (8.36M) with profit before overhead, payroll, taxes, and interest of 5.21K.
CANNABIS SCIENCE currently holds about 29.29K in cash with (1.58M) of positive cash flow from operations.

Cannabis Science Returns Distribution Density

Mean Return0.33Value At Risk6.25
Potential Upside3.57Standard Deviation3.03
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Neville Rodie Shaw IncCommon Shares20 K1000
Rothschild Investment CorpCommon Shares14 K0.0
Sky Investment Group LlcCommon Shares157 K6 K
Donaldson Capital Management LlcCommon Shares99.8 K4 K
Rothschild Investment CorpCommon Shares14 K1000
Neville Rodie Shaw IncCommon Shares20 K1000
Edge Wealth Management LlcCommon Shares15 K1000

Cannabis Science Greeks

α
Alpha over DOW
=0.55
β
Beta against DOW=1.39
σ
Overall volatility
=3.02
Ir
Information ratio =0.16

Cannabis Science Volatility Alert

Cannabis Science exhibits very low volatility with skewness of -0.25 and kurtosis of -0.31. However, we advise investors to further study Cannabis Science technical indicators to make sure all market info is available and is reliable. Cannabis Science is a penny stock. Although Cannabis Science may be in fact a good investment, many penny stocks are subject to artificial stock hype. Make sure you completely understand upside potential and downside risk of investing in Cannabis Science. We encourage investors to look for the signals such us message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
    
 Better Than Average     
    
 Worse Than Average Compare Cannabis Science to competition

Cannabis Science Fundamental Vs Peers

FundamentalsCannabis SciencePeer Average
Return On Equity(5.10)% (0.31)%
Return On Asset(384.61)% (0.14)%
Current Valuation77.44M16.62B
Shares Outstanding2.55B571.82M
Shares Owned by Insiders0.11% 10.09%
Shares Owned by Institutions0.03% 39.21%
Price to Earning(6.16)X28.72X
Revenue7.04K9.43B
Gross Profit5.21K27.38B
EBITDA(9.58M)3.9B
Net Income(8.36M)570.98M
Cash and Equivalents29.29K2.7B
Total Debt2.73M5.32B
Current Ratio0.09X2.16X
Cash Flow from Operations(1.58M)971.22M
Earnings Per Share(0.003)X3.12X
Number of Employees118.84K
Beta-0.4-0.15
Market Capitalization76.55M19.03B
Total Asset1.08M29.47B
Retained Earnings(139.97M)9.33B
Working Capital(5.03M)1.48B
Current Asset395K9.34B
Current Liabilities5.43M7.9B
   Sale by Robert Kane of 45000 shares of Cannabis Science [view details]
Search macroaxis.com